meta
|
evidence
oncology
Living systematic review and meta-analysis
RET gene alteration defined cancer
2
glioblastoma (GB)
1
immune chekpoint inhibitors
anti-CTLA-4
ipilimumab based treatment
ipilimumab plus SoC
anti-PD-(L)1
nivolumab based treatment
nivolumab alone
pembrolizumab based treatment
pembrolizumab plus SoC
no study with result for this clinical condition